Herbert C. Buchanan Jr joins Noxilizer board of directors
Noxilizer to leverage Buchanan's leadership and healthcare expertise to drive market growth and expansion.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
10 Feb 15
Noxilizer to leverage Buchanan's leadership and healthcare expertise to drive market growth and expansion.
30 Jan 15
Consumers in the US saw branded drug prices rise by 14.8% last year, according to Truveris, a leading…
29 Jan 15
A study by researchers at King's College London has found that childhood obesity among young children has started…
12 Dec 14
Diagnostic X-ray is the most widely used technique for early detection of disease. GlobalData analyses the market up…
11 Nov 14
The pharmaceutical industry is witnessing a new wave of mergers and acquisitions, especially so-called ‘mega M&As’. As Big…
11 Nov 14
With healthcare costs and expenditure rising in China, healthcare clusters and innovative focus groups will play a crucial…
31 Oct 14
Sales of drugs to treat age-related macular degeneration in the G7 pharmaceutical markets are set to grow 6%…
30 Oct 14
Power tools are key for many orthopaedic procedures. Driven by the industry’s continued innovation in cordless battery-powered systems…
09 Oct 14
The UK’s early adoption of next-generation surgical appliances and its move away from invasive procedures for treating cancer,…
04 Jul 14
Swiss giant Roche is to pay $725 million to acquire breast cancer specialist Seragon Pharmaceuticals.